Responsible Institution: China Association for Science and Technology
Sponsored by: The Chinese Pharmacological Society
Editor-in-Chief: HUANG Zhili
ISSN 1009-2501
CN 34-1206/R
CHAI Xiao-Qing, CHEN Kun-Zhou. Urapidil and nitroglycerine for the control of cardiovascular responses to tracheal intubation/extubation in patients with essential hypertension[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(1): 51-53.
1 Edwards ND, Alford AM, Dobson PM, et al.Myocardial is-chaemia during tracheal intubation and extubation[J]. Br J Anaesth, 1994;73:537-9 2 刘正美, 杭燕南.围拔管期高血压[J]. 国外医学麻醉学与复苏分册, 1996;17:289-92 3 Langtry HD, Mammen GJ, Sorkin EM.Urapidil a review of its pharmacodynamic and pharmacokinetic properties, and thera-peutic potential in the treatment of hypertension[J]. Drugs, 1989;38:900-40 4 Kolassa N, Beller KD, Sanders KH.Involvement of brain 5-HT 1A receptors in the hypotensive response to urapidil[J]. Am J Cardiol, 1989;64:7D-10D 5 Ye T, Luo A, Ren H, et al.Preliminary report on cardiovas-cular responses to urapidil during intubation and extubation[J]. ClinMed Sci J, 1993;8:240-2 6 Hirschl MM, Seilder D, Zeiner A, et al.Intravenous urapidil versus sublingual nifedipine in the treatment of hypertensive e-mergencies[J]. Minerva Cardioangiol.1994;42:365-71